Second-look US identification prior to guided biopsy.
Luc ROTENBERG
What is the status of pathologists in the context of a multidisciplinary tumor boards?
Fréderique PENAULT LORCA
Chairwoman of the Pathology department, University Hospital, Clermont Ferrand, France
Therapeutic options and adjuvant therapy.
16.30 I 16.45
Maroun KHOURY
New advance in Oncology in UAE
Humaid AL SHAMSI
Hormone Receptor-Positive Breast Cancer: Emerging Treatments
Georgia DEMETRIOU